Dx & Vx Co Ltd
KOSDAQ:180400
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Dx & Vx Co Ltd
KOSDAQ:180400
|
KR |
|
Unozawa-gumi Iron Works Ltd
TSE:6396
|
JP |
|
Grand Banks Yachts Ltd
SGX:G50
|
SG |
|
H
|
Hong Leong Industries Bhd
KLSE:HLIND
|
MY |
|
H
|
Hao Tian International Construction Investment Group Ltd
HKEX:1341
|
HK |
|
Frasers Property Ltd
SGX:TQ5
|
SG |
|
Real Matters Inc
TSX:REAL
|
CA |
|
Towa Pharmaceutical Co Ltd
TSE:4553
|
JP |
|
A
|
Ahlada Engineers Ltd
NSE:AHLADA
|
IN |
|
MTY Food Group Inc
TSX:MTY
|
CA |
|
Antipa Minerals Ltd
ASX:AZY
|
AU |
|
Computer Engineering & Consulting Ltd
TSE:9692
|
JP |
|
Base Inc
TSE:4477
|
JP |
|
Halcyon Agri Corporation Ltd
SGX:5VJ
|
SG |
|
United Security Bancshares
NASDAQ:UBFO
|
US |
|
Delegat Group Ltd
NZX:DGL
|
NZ |
|
F
|
Fanuc Corp
F:FUC
|
JP |
|
H
|
HK Acquisition Corp
HKEX:7841
|
HK |
|
Quanex Building Products Corp
NYSE:NX
|
US |
|
J
|
Jazan Energy and Development Company SJSC
SAU:6090
|
SA |
|
B
|
Ben Thanh Rubber JSC
VN:BRC
|
VN |
|
A
|
Alset Ehome International Inc
NASDAQ:AEI
|
US |
|
Nippon Beet Sugar Manufacturing Co Ltd
TSE:2108
|
JP |
|
A
|
Avicopter PLC
SSE:600038
|
CN |
Multiples-Based Value
The Multiples-Based Value for Dx & Vx Co Ltd (180400) under the Base Case is hidden KRW. Compared with the current market price of 7 740 KRW, the stock appears hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
Dx & Vx Co Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
D
|
Dx & Vx Co Ltd
KOSDAQ:180400
|
381B KRW | 14 | -7.5 | -7.6 | -7.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.4 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.5 | 40.5 | 41.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |